Latest News about Biotech
Recent news which mentions Biotech
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
From Benzinga
Cardio Diagnostics' Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association
December 15, 2023
Tickers
CDIO
From Benzinga
French Drugmaker Sanofi Secures European Medicines Agency's Positive Opinion For Sleeping Sickness Treatment
December 15, 2023
Tickers
SNY
From Benzinga
Alector Upgraded, Analyst Sees High Reward Potential Ahead of Alzheimer's Disease Candidate's Phase 2 Results
December 14, 2023
Tickers
ALEC
From Benzinga
Why Is Apellis Pharmaceuticals Stock Trading Lower Today?
December 14, 2023
Tickers
APLS
From Benzinga
Moderna Stock Is Soaring Today - Here's Why
December 14, 2023
From Benzinga
A Look At Elicio Therapeutics' (NASDAQ: ELTX) Pipeline: What Does This Cancer-Fighting Company Have In Store For The Future?
December 14, 2023
Tickers
ELTX
From Benzinga
Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ: TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL
December 14, 2023
Tickers
TNXP
From Benzinga
Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut
December 14, 2023
From Benzinga
Supreme Court Set to Decide Future of Mifepristone: Showdown Looms Over FDA's Endorsement
December 13, 2023
From Benzinga
Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside
December 13, 2023
From Benzinga
From Benzinga
Vertex's Non-Opioid Diabetes Associated Nerve Pain Treatment Candidate Aces Mid-Stage Trial
December 13, 2023
Tickers
VRTX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.